Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis

NCT00645073 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

271

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Bacterial Sinusitis

Interventions

DRUG: cefdinir (Omnicef)
DRUG: levofloxacin

Sponsor

Abbott